Oncopeptides AB (publ) reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SEK 25.95 million compared to SEK 8.75 million a year ago. Net loss was SEK 56.33 million compared to SEK 59.83 million a year ago.
For the six months, sales was SEK 27.08 million compared to SEK 8.75 million a year ago. Net loss was SEK 127.36 million compared to SEK 158.41 million a year ago.